Skip to main content

Table 3 Discharge medications according to ACS subtypes

From: Management quality indicators and in-hospital mortality among acute coronary syndrome patients admitted to tertiary hospitals in Ethiopia: prospective observational study

Discharge medications

All patients (n = 144)

STEMI (n = 82)

NSTE-ACS (n = 62)

p-value

Aspirin

140 (97.2)

82 (100.0)

58 (93.5)

0.020

Clopidogrel

109 (75.7)

69 (84.1)

40 (64.5)

0.007

DAPT

109 (75.7)

69 (84.1)

40 (64.5)

0.007

Beta-blockers

120 (83.3)

72 (87.8)

48 (77.4)

0.098

ACEIs/ARBs

109 (75.7)

67 (81.7)

42 (67.7)

0.053

Statins

138 (95.8)

80 (97.6)

58 (93.5)

0.233

  1. ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin-receptor blockers, NSTE-ACS Non-ST-elevation acute coronary syndrome, STEMI ST-elevation myocardial infarction; a*statistically significant at p < 0.05